{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:24:06Z","timestamp":1789799046921,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In-hospital acute resuscitation in trauma has evolved toward early and balanced transfusion resuscitation with red blood cells (RBC) and plasma being transfused in equal ratios. Being able to deliver this ratio in prehospital environments is a challenge. A combined component, like leukocyte-depleted red cell and plasma (RCP), could facilitate early prehospital resuscitation with RBC and plasma, while at the same time improving logistics for the team. However, there is limited evidence on the clinical benefits of RCP.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To compare prehospital transfusion of combined RCP versus RBC alone or RBC and plasma separately (RBC\u2009+\u2009P) on mortality in trauma bleeding patients.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data were collected prospectively on patients who received prehospital transfusion (RBC\u2009+\u2009thawed plasma\/Lyoplas or RCP) for traumatic hemorrhage from six prehospital services in England (2018\u20132020). Retrospective data on patients who transfused RBC from 2015 to 2018 were included for comparison. The association between transfusion arms and 24-h and 30-day mortality, adjusting for age, injury mechanism, age, prehospital heart rate and blood pressure, was evaluated using generalized estimating equations.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of 970 recruited patients, 909 fulfilled the study criteria (RBC\u2009+\u2009P\u2009=\u2009391, RCP\u2009=\u2009295, RBC\u2009=\u2009223). RBC\u2009+\u2009P patients were older (mean age 42 vs 35\u00a0years for RCP and RBC), and 80% had a blunt injury (RCP\u2009=\u200952%, RBC\u2009=\u200956%). RCP and RBC\u2009+\u2009P were associated with lower odds of death at 24-h, compared to RBC alone (adjusted odds ratio [aOR] 0.69 [95%CI: 0.52; 0.92] and 0.60 [95%CI: 0.32; 1.13], respectively). The lower odds of death for RBC\u2009+\u2009P and RCP vs RBC were driven by penetrating injury (aOR 0.22 [95%CI: 0.10; 0.53] and 0.39 [95%CI: 0.20; 0.76], respectively). There was no association between RCP or RBC\u2009+\u2009P with 30-day survival vs RBC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Prehospital plasma transfusion for penetrating injury was associated with lower odds of death at 24-h compared to RBC alone. Large trials are needed to confirm these findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-022-04279-4","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T16:03:36Z","timestamp":1673971416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Association of red blood cells and plasma transfusion versus red blood cell transfusion only with survival for treatment of major traumatic hemorrhage in prehospital setting in England: a multicenter study"],"prefix":"10.1186","volume":"27","author":[{"given":"Harriet","family":"Tucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Brohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Aylwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bloomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cardigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"McCullagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Stanworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Uprichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"issue":"16","key":"4279_CR1","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1001\/jama.2017.15097","volume":"318","author":"SA Shackelford","year":"2017","unstructured":"Shackelford SA, Del Junco DJ, Powell-Dunford N, Mazuchowski EL, Howard JT, Kotwal RS, et al. Association of prehospital blood product transfusion during medical evacuation of combat casualties in Afghanistan with acute and 30-day survival. JAMA. 2017;318(16):1581\u201391.","journal-title":"JAMA"},{"issue":"5","key":"4279_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jama.2015.12","volume":"313","author":"JB Holcomb","year":"2015","unstructured":"Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471\u201382.","journal-title":"JAMA"},{"issue":"6","key":"4279_CR3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/bjh.13580","volume":"170","author":"BJ Hunt","year":"2015","unstructured":"Hunt BJ, Allard S, Keeling D, Norfolk D, Stanworth SJ, Pendry K, et al. A practical guideline for the haematological management of major haemorrhage. Br J Haematol. 2015;170(6):788\u2013803.","journal-title":"Br J Haematol"},{"issue":"1","key":"4279_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13054-019-2347-3","volume":"23","author":"DR Spahn","year":"2019","unstructured":"Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt BJ, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019;23(1):98.","journal-title":"Crit Care"},{"issue":"1","key":"4279_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13049-018-0567-1","volume":"26","author":"JE Griggs","year":"2018","unstructured":"Griggs JE, Jeyanathan J, Joy M, Russell MQ, Durge N, Bootland D, et al. Mortality of civilian patients with suspected traumatic haemorrhage receiving prehospital transfusion of packed red blood cells compared to prehospital crystalloid. Scand J Trauma Resusc Emerg Med. 2018;26(1):100.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"3","key":"4279_CR6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/SHK.0000000000001166","volume":"51","author":"M Rehn","year":"2019","unstructured":"Rehn M, Weaver A, Brohi K, Eshelby S, Green L, Roislien J, et al. Effect of prehospital red blood cell transfusion on mortality and time of death in civilian trauma patients. Shock. 2019;51(3):284\u20138.","journal-title":"Shock"},{"key":"4279_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00040-0","author":"N Crombie","year":"2022","unstructured":"Crombie N, Doughty HA, Bishop JRB, Desai A, Dixon EF, Hancox JM, et al. Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Haematol. 2022. https:\/\/doi.org\/10.1016\/S2352-3026(22)00040-0.","journal-title":"Lancet Haematol"},{"issue":"10144","key":"4279_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(18)31553-8","volume":"392","author":"HB Moore","year":"2018","unstructured":"Moore HB, Moore EE, Chapman MP, McVaney K, Bryskiewicz G, Blechar R, et al. Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial. Lancet. 2018;392(10144):283\u201391.","journal-title":"Lancet"},{"issue":"4","key":"4279_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1056\/NEJMoa1802345","volume":"379","author":"JL Sperry","year":"2018","unstructured":"Sperry JL, Guyette FX, Brown JB, Yazer MH, Triulzi DJ, Early-Young BJ, et al. Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock. N Engl J Med. 2018;379(4):315\u201326.","journal-title":"N Engl J Med"},{"issue":"1","key":"4279_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/TA.0000000000002485","volume":"88","author":"KM Reitz","year":"2020","unstructured":"Reitz KM, Moore HB, Guyette FX, Sauaia A, Pusateri AE, Moore EE, et al. Prehospital plasma in injured patients is associated with survival principally in blunt injury: results from two randomized prehospital plasma trials. J Trauma Acute Care Surg. 2020;88(1):33\u201341.","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"4279_CR11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/SLA.0000000000003324","volume":"273","author":"FX Guyette","year":"2021","unstructured":"Guyette FX, Sperry JL, Peitzman AB, Billiar TR, Daley BJ, Miller RS, et al. Prehospital blood product and crystalloid resuscitation in the severely injured patient: a secondary analysis of the prehospital air medical plasma trial. Ann Surg. 2021;273(2):358\u201364.","journal-title":"Ann Surg"},{"issue":"4","key":"4279_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tmrv.2021.08.004","volume":"35","author":"H Tucker","year":"2021","unstructured":"Tucker H, Davenport R, Green L. The role of plasma transfusion in prehospital haemostatic resuscitation. Transfus Med Rev. 2021;35(4):91\u20135.","journal-title":"Transfus Med Rev"},{"key":"4279_CR13","doi-asserted-by":"crossref","unstructured":"Pusateri AE, Moore EE, Moore HB, Le TD, Guyette FX, Chapman MP, et al. Association of prehospital plasma transfusion with survival in trauma patients with hemorrhagic shock when transport times are longer than 20 minutes: a post hoc analysis of the PAMPer and COMBAT clinical trials. JAMA Surg. 2019; e195085.","DOI":"10.1001\/jamasurg.2019.5085"},{"issue":"Suppl 1","key":"4279_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/SHK.0000000000000134","volume":"41","author":"AD Murdock","year":"2014","unstructured":"Murdock AD, Berseus O, Hervig T, Strandenes G, Lunde TH. Whole blood: the future of traumatic hemorrhagic shock resuscitation. Shock. 2014;41(Suppl 1):62\u20139.","journal-title":"Shock"},{"key":"4279_CR15","doi-asserted-by":"crossref","unstructured":"Avery P, Morton S, Tucker H, Green L, Weaver A, Davenport R. Whole blood transfusion versus component therapy in adult trauma patients with acute major haemorrhage. Emerg Med J; 2020.","DOI":"10.1136\/emermed-2019-209040"},{"issue":"2","key":"4279_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.injury.2020.10.095","volume":"52","author":"M Malkin","year":"2021","unstructured":"Malkin M, Nevo A, Brundage SI, Schreiber M. Effectiveness and safety of whole blood compared to balanced blood components in resuscitation of hemorrhaging trauma patients\u2013a systematic review. Injury. 2021;52(2):182\u20138.","journal-title":"Injury"},{"key":"4279_CR17","doi-asserted-by":"crossref","unstructured":"Geneen LJ, Brunskill SJ, Doree C, Estcourt LJ, Green L. The difference in potential harms between whole blood and component blood transfusion in major bleeding: a rapid systematic review and meta-analysis of RCTs. Transfus Med Rev. 2021.","DOI":"10.1016\/j.tmrv.2021.10.003"},{"issue":"11","key":"4279_CR18","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1111\/trf.15549","volume":"59","author":"S Huish","year":"2019","unstructured":"Huish S, Green L, Curnow E, Wiltshire M, Cardigan R. Effect of storage of plasma in the presence of red blood cells and platelets: re-evaluating the shelf life of whole blood. Transfusion. 2019;59(11):3468\u201377.","journal-title":"Transfusion"},{"key":"4279_CR19","doi-asserted-by":"crossref","unstructured":"Stanworth SJ, Dowling K, Curry N, et al. Haematological management of major haemorrhage: a British Society for Haematology Guideline. Br J Haematol. 2022;198(4):654\u2013667.","DOI":"10.1111\/bjh.18275"},{"issue":"1","key":"4279_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/SHK.0000000000000569","volume":"46","author":"IM Smith","year":"2016","unstructured":"Smith IM, James RH, Dretzke J, Midwinter MJ. Prehospital blood product resuscitation for trauma: a systematic review. Shock. 2016;46(1):3\u201316.","journal-title":"Shock"},{"issue":"3","key":"4279_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/SLA.0000000000004563","volume":"273","author":"JB Holcomb","year":"2021","unstructured":"Holcomb JB, Moore EE, Sperry JL, Jansen JO, Schreiber MA, Del Junco DJ, et al. Evidence-based and clinically relevant outcomes for hemorrhage control trauma trials. Ann Surg. 2021;273(3):395\u2013401.","journal-title":"Ann Surg"},{"issue":"1","key":"4279_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.injury.2016.10.037","volume":"48","author":"BT Oyeniyi","year":"2017","unstructured":"Oyeniyi BT, Fox EE, Scerbo M, Tomasek JS, Wade CE, Holcomb JB. Trends in 1029 trauma deaths at a level 1 trauma center: impact of a bleeding control bundle of care. Injury. 2017;48(1):5\u201312.","journal-title":"Injury"},{"issue":"Suppl 1","key":"4279_CR23","first-page":"S55","volume":"69","author":"S Pati","year":"2010","unstructured":"Pati S, Matijevic N, Doursout MF, Ko T, Cao Y, Deng X, et al. Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma. 2010;69(Suppl 1):S55\u201363.","journal-title":"J Trauma"},{"issue":"1","key":"4279_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/SHK.0000000000000918","volume":"49","author":"R Chang","year":"2018","unstructured":"Chang R, Holcomb JB, Johansson PI, Pati S, Schreiber MA, Wade CE. Plasma resuscitation improved survival in a Cecal ligation and puncture rat model of sepsis. Shock. 2018;49(1):53\u201361.","journal-title":"Shock"},{"key":"4279_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13054-015-0828-6","volume":"19","author":"M Straat","year":"2015","unstructured":"Straat M, Muller MC, Meijers JC, Arbous MS, Spoelstra-de Man AM, Beurskens CJ, et al. Effect of transfusion of fresh frozen plasma on parameters of endothelial condition and inflammatory status in non-bleeding critically ill patients: a prospective substudy of a randomized trial. Crit Care. 2015;19:163.","journal-title":"Crit Care"},{"issue":"6S Suppl 1","key":"4279_CR26","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1097\/TA.0000000000001820","volume":"84","author":"S Shah","year":"2018","unstructured":"Shah S, Coppolino K, Menocha S, Beceiro S, Nateri J, Spinella PC, et al. Immunomodulatory effects of plasma products on monocyte function in vitro. J Trauma Acute Care Surg. 2018;84(6S Suppl 1):S47\u201353.","journal-title":"J Trauma Acute Care Surg"},{"issue":"10224","key":"4279_CR27","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S0140-6736(19)33157-5","volume":"395","author":"MP Chapman","year":"2020","unstructured":"Chapman MP, Moore EE, Moore HB, Sauaia A. Plasma-first resuscitation to treat haemorrhagic shock in urban areas\u2013authors\u2019 reply. Lancet. 2020;395(10224):562\u20133.","journal-title":"Lancet"},{"issue":"1","key":"4279_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/vox.12251","volume":"109","author":"R Cardigan","year":"2015","unstructured":"Cardigan R, Green L. Thawed and liquid plasma\u2013what do we know? Vox Sang. 2015;109(1):1\u201310.","journal-title":"Vox Sang"},{"key":"4279_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2021-001396","author":"J McCullagh","year":"2021","unstructured":"McCullagh J, Proudlove N, Tucker H, Davies J, Edmondson D, Lancut J, et al. Making every drop count: reducing wastage of a novel blood component for transfusion of trauma patients. BMJ Open Qual. 2021. https:\/\/doi.org\/10.1136\/bmjoq-2021-001396.","journal-title":"BMJ Open Qual"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04279-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-04279-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04279-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T16:05:20Z","timestamp":1673971520000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-04279-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4279"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-04279-4","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]},"assertion":[{"value":"29 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study received ethical approval from the Health Research Authority (IRAS reference: 236783). Due to the study design, consent from patients was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare the following: LG, RC, SS are employees of NHSBT and report obtaining research funds for multiple clinical studies, but they report no direct relevant financial disclosures. All other authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}